We are live on ! Find out more
RJA

Raymond James & Associates Portfolio holdings

AUM $164B
1-Year Est. Return 33.91%
This Fund
S&P 500
This Quarter Est. Return
+19.36%
1 Year Est. Return
+33.91%
3 Year Est. Return
+39.99%
5 Year Est. Return
+107.66%
10 Year Est. Return
+436.07%
AUM
$74.6B
AUM Growth
+$11.6B
Cap. Flow
+$749M
Cap. Flow %
1%
Top 10 Hldgs %
23.84%
Holding
3,748
New
262
Increased
1,669
Reduced
1,459
Closed
235

Sector Composition

Rank Sector Weight
1 Technology 14.03%
2 Healthcare 8.95%
3 Financials 8.03%
4 Consumer Discretionary 6.23%
5 Industrials 5.99%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DHR icon
101
Danaher
DHR
$144B
$132M 0.18%
840,282
+44,918
+6% +$6.45M
ADSK icon
102
Autodesk
ADSK
$52.6B
$130M 0.17%
545,301
+15,784
+3% +$3.1M
DUK icon
103
Duke Energy
DUK
$97.3B
$130M 0.17%
1,628,453
-147,104
-8% -$12.4M
BBY icon
104
Best Buy
BBY
$17.3B
$130M 0.17%
1,490,195
+988,014
+197% +$74.9M
PNC icon
105
PNC Financial Services
PNC
$101B
$129M 0.17%
1,225,316
+32,462
+3% +$3.42M
ARKK icon
106
ARK Innovation ETF
ARKK
$6.29B
$129M 0.17%
1,804,583
+161,840
+10% +$9.47M
GILD icon
107
Gilead Sciences
GILD
$165B
$129M 0.17%
1,672,389
-607,851
-27% -$46.6M
IAU icon
108
iShares Gold Trust
IAU
$64.4B
$128M 0.17%
3,780,933
+418,267
+12% +$13.7M
BA icon
109
Boeing
BA
$185B
$128M 0.17%
698,719
+178,962
+34% +$27.5M
TFC icon
110
Truist Financial
TFC
$64B
$127M 0.17%
3,382,083
-155,263
-4% -$5.59M
HON icon
111
Honeywell
HON
$78B
$125M 0.17%
916,979
-187,203
-17% -$24.8M
LLY icon
112
Eli Lilly
LLY
$1.06T
$123M 0.17%
752,022
-39,569
-5% -$6.07M
LQD icon
113
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
$32.8B
$123M 0.17%
916,840
+228,828
+33% +$29.8M
TMO icon
114
Thermo Fisher Scientific
TMO
$220B
$121M 0.16%
333,970
+12,205
+4% +$4.09M
VEU icon
115
Vanguard FTSE All-World ex-US ETF
VEU
$70.2B
$121M 0.16%
2,540,049
+139,894
+6% +$6.27M
MMM icon
116
3M
MMM
$94.3B
$120M 0.16%
922,947
+161,402
+21% +$20.3M
GSK icon
117
GSK
GSK
$106B
$118M 0.16%
2,315,934
-295,777
-11% -$15.2M
ZTS icon
118
Zoetis
ZTS
$30B
$118M 0.16%
859,044
+27,554
+3% +$3.6M
ORCL icon
119
Oracle
ORCL
$423B
$117M 0.16%
2,120,198
+32,341
+2% +$1.71M
VGT icon
120
Vanguard Information Technology ETF
VGT
$149B
$115M 0.15%
3,302,704
-33,192
-1% -$1.04M
RSP icon
121
Invesco S&P 500 Equal Weight ETF
RSP
$99.1B
$115M 0.15%
1,130,017
-262,908
-19% -$25.4M
NKE icon
122
Nike
NKE
$61.9B
$114M 0.15%
1,166,592
+102,816
+10% +$9.49M
VCIT icon
123
Vanguard Intermediate-Term Corporate Bond ETF
VCIT
$67.8B
$114M 0.15%
1,197,322
+89,588
+8% +$8.24M
XLF icon
124
State Street Financial Select Sector SPDR ETF
XLF
$58.8B
$112M 0.15%
4,860,341
+2,138,361
+79% +$48.6M
NVS icon
125
Novartis
NVS
$297B
$112M 0.15%
1,281,769
+12,319
+1% +$1.06M

Similar funds

Raymond James & Associates's Q2 2020 Portfolio in Review

As of Q2 2020, Raymond James & Associates held 3,748 positions worth $74.6B, up 18% from $63B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Raymond James & Associates's Q2 2020 filing shows 262 new, 1,669 increased, 1,459 reduced and 235 closed positions. Its largest new stake was Carrier Global: 1,148,017 shares worth $25.5M. The largest sale was iShares Core MSCI EAFE ETF, an estimated $487M.

By sector, the portfolio is most concentrated in Technology at 14% of assets, up from 12% a quarter earlier, followed by Healthcare and Financials.

  • Raymond James & Associates's largest Q2 2020 buy was Carrier Global: 1,148,017 shares worth $25.5M.
  • Raymond James & Associates added most to iShares Broad USD High Yield Corporate Bond ETF in Q2 2020, an estimated $312M increase.
  • Raymond James & Associates's biggest Q2 2020 reduction was iShares Core MSCI EAFE ETF, cutting an estimated $487M.
  • Raymond James & Associates fully exited Raytheon Company in Q2 2020, selling an estimated $73.9M.
  • Raymond James & Associates's ten largest holdings make up 24% of its $74.6B portfolio in Q2 2020.
  • Raymond James & Associates opened 262 new positions and closed 235 in Q2 2020.
  • Raymond James & Associates's portfolio value rose 18% quarter-over-quarter to $74.6B.

Based on Raymond James & Associates's 13F filing for Q2 2020, filed 28 Jul 2020.